Barriers and Facilitators for Clostridium difficile Bundle Implementation
Barriers and Facilitators for Clostridium difficile Bundle Implementation
批准号:
8671210
负责人:
NASIA SAFDAR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2015-05-31
关键词:
AddressAdherenceAdoptionAffectAmericanAmericasAntibioticsAntimicrobial ResistanceAttitudeBeliefCaringCenters for Disease Control and Prevention (U.S.)Cessation of lifeClostridium difficileCommunicable DiseasesComplementComplexContainmentDataData CollectionDecision MakingDecontaminationDiagnostic testsDiarrheaDisease OutbreaksDisinfectionElementsEngineeringEnsureFocus GroupsGenerationsGuidelinesHandHealth PersonnelHealth Services ResearchHealth care facilityHealthcareHospitalsHygieneIncidenceIndividualInfectionInfection ControlInfection preventionInstitutionInterventionJudgmentLiteratureMeasuresMethodologyMethodsMilitary PersonnelModelingMonitorMorbidity - disease rateMulti-Drug ResistanceNursesOrganismPaperParticipantPatient IsolationPatientsPatients&apos RoomsPerceptionPhysiciansPilot ProjectsPreventionPrevention strategyPreventiveProcessProphylactic treatmentReproduction sporesResearchRibotypesRibotypingRiskServicesSeveritiesSimulateSocietiesSystemSystems AnalysisThromboembolismUniversitiesVenousVeteransWorkbasecostdesigndirect patient caredisorder preventionfluoroquinolone resistancehealth care qualityinnovationmeetingsmethicillin resistant Staphylococcus aureuspathogenpatient safetyportabilitypreventprogramspublic health prioritiesrapid diagnosisresearch studyresistant straintooltransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Impact: Prevention of Clostridium difficile is a priority of the VA, and implementation of a C. difficile
prevention bundle, akin to an already established methicillin-resistant Staphylococcus aureus (MRSA) bundle,
has recently been rolled out nationally. However, our ability to devise and implement strategies for containment
of C. difficile is hampered by a limited understanding of factors influencing acquisition, spread, and prevention
of C. difficile. Immediate benefits of achieving the objectives of this proposal will be generation of important
data regarding barriers and facilitators of implementation using a systems engineering approach. Our study
will produce data, methods, and tools that have widespread relevance and portability, with the potential to
reduce healthcare-associated infections (HAIs) including but not limited to C. difficile infection.
Background: C. difficile is the major infectious cause of nosocomial diarrhea, causing as many as 25%
of cases of nosocomial diarrhea. C. difficile infection (CDI) is increasing in incidence and severity, affects
500,000 Americans each year, causes 20,000 deaths annually, and imposes a significant financial burden on
healthcare institutions - $1.1 billion annually in the U.S. Preventing CDI is essential; thus, the Veterans Affairs
Multidrug Resistant Organism (MDRO) Program Office has recently mandated a national bundle for prevention
of CDI at VA facilities. The bundle includes appropriate diagnostic testing, optimization of hand hygiene
compliance by monitoring, contact isolation for CDI, and environmental cleaning of rooms of patients with CDI.
However, it does not address optimum implementation strategies to ensure successful application of these
interventions. Nor does it prescribe how these measures may be undertaken. Implementing and adhering to
these recommended measures varies considerably across institutions.
Objectives: We hypothesize that a number of work system barriers may pose challenges to successful
acceptance, adoption, and implementation of the CDI bundle. Our objective is to assess work system barriers
and facilitators to bundle implementation using a mixed-methods approach. We will undertake direct
observations of practices relevant to CDI prevention; conduct focus groups of healthcare workers (HCWs); and
use vignettes to examine HCW perceptions, attitudes, & decision-making about CDI prevention.
Methods: We will use the innovative Systems Engineering Initiative for Patient Safety (SEIPS) model of
work system and patient safety as the study framework. This model, as well as general literature on guideline
implementation, will guide focus group questions. Three focus groups will be conducted. Participants will
include nurses, physicians, and environmental services. Each session will include 4-5 open-ended questions
(covering 60-90 min). We will design paper case vignettes depicting patients with or at risk for CDI, and we will
ask physicians, nurses, and environmental services staff about relevant infection control practices for CDI
prevention. Healthcare workers will be asked whether they would undertake diagnostic testing for CDI and
whether they would prescribe empiric treatment, isolation, or reduce concomitant antibiotics. Vignette data will
be analyzed using the method of judgment analysis. Finally, we will conduct direct observations of HCWs
based on the SEIPS model. We will observe patient rooms, individuals, tasks, and organization to better
understand the overall work system that surrounds the process of care for CDI patients.
This is among the first research studies to systematically examine barriers and facilitators of implemen-
tation of a prevention bundle for CDI, which is a major HAI. Our project is innovative in that it will employ the
SEIPS framework to undertake a complete work systems analysis for CDI prevention; use a number of
complementary approaches to data collection; and consider not just HCWs involved in direct patient care, but
also ancillary staff who are critical to successful CDI prevention. Our study methods and approach may be
widely used not just for CDI but also other HAIs, and will add to the fields of patient safety and infection control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BCCMA: Targeting Gut-Microbiome in Veterans Deployment related Gastrointestinal and Liver diseases; CMA5- Functional metagenomics in GWI-related gut dysfunction
-
批准号:10588620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:NASIA SAFDAR
-
依托单位:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
-
批准号:10641758
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:NASIA SAFDAR
-
依托单位:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
-
批准号:9720132
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:NASIA SAFDAR
-
依托单位:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
-
批准号:10404905
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:NASIA SAFDAR
-
依托单位:
Reducing VA Healthcare-Associated Infections through Antibiotic StEwardship (RAISE)
-
批准号:10181069
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:NASIA SAFDAR
-
依托单位:
Identification of novel MDR antimicrobials from human microbiome symbioses
-
批准号:10592388
-
项目类别:
-
资助金额:$126.61万
-
财政年份:2019
-
负责人:NASIA SAFDAR
-
依托单位:
Identification of novel MDR antimicrobials from human microbiome symbioses
-
批准号:10571221
-
项目类别:
-
资助金额:$106.02万
-
财政年份:2019
-
负责人:NASIA SAFDAR
-
依托单位:
Mentored Enhanced Implementation and Evaluation of National VA Mandates To Prevent The Spread Of C Difficile infection
-
批准号:10216348
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients
-
批准号:10462715
-
项目类别:
-
资助金额:$102.21万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
-
批准号:9753142
-
项目类别:
-
资助金额:$49.04万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
-
批准号:10165788
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
-
批准号:10411933
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Mentored Enhanced Implementation and Evaluation of National VA Mandates To Prevent The Spread Of C Difficile infection
-
批准号:10290896
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients
-
批准号:10241381
-
项目类别:
-
资助金额:$100.54万
-
财政年份:2018
-
负责人:NASIA SAFDAR
-
依托单位:
Efficacy of oral vancomycin prophylaxis for prevention of recurrent C. difficile infection
-
批准号:10202724
-
项目类别:
-
资助金额:$46.47万
-
财政年份:2017
-
负责人:NASIA SAFDAR
-
依托单位:
Efficacy of oral vancomycin prophylaxis for prevention of recurrent C. difficile infection
-
批准号:9424172
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2017
-
负责人:NASIA SAFDAR
-
依托单位:
The GRAFT study: Gut RecolonizAtion by Fecal Transplantation
-
批准号:9297849
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:NASIA SAFDAR
-
依托单位:
Building implementation science for VA healthcare associated infection prevention
-
批准号:9063308
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:NASIA SAFDAR
-
依托单位:
Implementation of Chlorhexidine Bathing to Reduce Healthcare-Associated Infections-the Icare study
-
批准号:9301469
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2015
-
负责人:NASIA SAFDAR
-
依托单位:
Implementation of Chlorhexidine Bathing to Reduce Healthcare-Associated Infections-the Icare study
-
批准号:8932185
-
项目类别:
-
资助金额:$48.89万
-
财政年份:2015
-
负责人:NASIA SAFDAR
-
依托单位:
海外基金